Naoi Yasuto, Tamaki Yasuhiro, Ooka Masaru, Tsukamoto Fumine, Miyoshi Yasuo, Tanji Yoshiro, Taguchi Tetsuya, Noguchi Shinzaburo
Dept. of Surgical Oncology, Graduate School of Medicine, Osaka University.
Gan To Kagaku Ryoho. 2003 Jan;30(1):145-9.
We report the case of a 58-year-old man with metastatic tumors 13 months after the initial surgery for paraganglioma at the left adrenal gland. A CT scan revealed a large tumor at the right scapula and abdominal paraaortic lymph nodes, and the patient received combination therapy of cyclophosphamide, vincristine and dacarbazine (CVD) every 3 to 4 weeks. After 11 courses, the serum catecholamine level was reduced to the normal range. The metastatic tumors showed optimal reduction in size, and the patient remains alive with no symptoms of the disease one year after the primary chemotherapy. The combination therapy of cyclophosphamide, vincristine and dacarbazine is considered a feasible and effective chemotherapy for metastatic malignant pheochromocytoma.
我们报告了一例58岁男性患者,该患者在左侧肾上腺副神经节瘤初次手术后13个月出现转移性肿瘤。CT扫描显示右肩胛骨处有一个大肿瘤以及腹主动脉旁淋巴结,患者每3至4周接受一次环磷酰胺、长春新碱和达卡巴嗪(CVD)联合治疗。经过11个疗程后,血清儿茶酚胺水平降至正常范围。转移性肿瘤大小明显缩小,在初次化疗一年后患者仍存活且无疾病症状。环磷酰胺、长春新碱和达卡巴嗪联合治疗被认为是转移性恶性嗜铬细胞瘤一种可行且有效的化疗方法。